Association between depressive symptoms and body fat in chronic kidney patients in hemodialysis
DOI:
https://doi.org/10.17267/2317-3394rpds.v10i3.3894Keywords:
Body Fat Distribution. , Chronic Kidney Disease, Depression. , Hemodialysis.Abstract
INTRODUCTION: Excess body fat causes complex metabolic changes that enhance the pathogenesis and progression of chronic kidney disease (CKD). Furthermore, negative behavioral aspects such as depressive symptoms and a sedentary lifestyle are common and may be associated with the accumulation of body fat in patients undergoing hemodialysis (HD) treatment. OBJECTIVE: To verify the association between depressive symptoms and body fat in HD patients. METHODS: This is a cross-sectional study that enrolled thirty-nine patients (59,3 ± 16,7; age). The body composition was evaluated by bioimpedance tetrapolar. Beck's depression inventory was used to measure depressive symptoms. To analyze the association between depressive symptoms and body fat, Spearman's correlation test was applied. RESULTS: A depression prevalence of 17.9% was observed. Depressive symptoms were positively correlated with body fat (r = 0.42; p = 0.008). CONCLUSION: In our results, we confirmed that depressive symptoms were associated with body fat in HD patients. These findings are important for the clinical practice of health professionals, especially in the dietary and psychological aspects, therefore, treatment initiatives for diagnosis, prevention are important to reduce these conditions.
Downloads
References
Aydemir, N., Pike, M. M., Alsouqi, A., Headley, S. A. E., Tuttle, K., Evans, E. E., Milch, C. M., Moody, K. A., Germain, M., Lipworth, L., Himmelfarb, J., Ikizler, T. A., & Robinson-Cohen, C. (2020). Effects of Diet and Exercise on Adipocytokine levels in Patients with Moderate to Severe Chronic Kidney Disease. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2020.04.012
Barros, A., Costa, B. E., Mottin, C. C., & D’Avila, D. O. (2016). Depression, quality of life, and body composition in patients with end-stage renal disease: A cohort study. Revista Brasileira de Psiquiatria, 38(4), 301–306. https://doi.org/10.1590/1516-4446-2015-1681
?wiek, A., Czok, M., Kurczab, B., Kramarczyk, K., Drzyzga, K., & Kucia, K. (2017). Association between depression and hemodialysis in patients with chronic kidney disease. Psychiatria Danubina, 29(Suppl 3), 499–503. https://pubmed.ncbi.nlm.nih.gov/28953816/
Debnath, S., O’Connor, J., Hura, C., Kasinath, B., & Lorenzo, C. (2018). Quality of Life and Depression Among Mexican Americans on Hemodialysis: A Preliminary Report. Therapeutic Apheresis and Dialysis, 22(2), 166–170. https://doi.org/10.1111/1744-9987.12642
Doll, H. A., Petersen, S. E. K., & Stewart-Brown, S. L. (2000). Obesity and Physical and Emotional Well-Being: Associations between Body Mass Index, Chronic Illness, and the Physical and Mental Components of the SF-36 Questionnaire. Obesity Research, 8(2), 160–170. https://doi.org/10.1038/oby.2000.17
Ferreira, T. L., Ribeiro, H. S., Ribeiro, A. L. A., Bonini-Rocha, A. C., Lucena, J. M. S., de Oliveira, P. A., Amorim, F. R. S., Ferreira, A. P., Magno, L. A. V., & Martins, W. R. (2021). Exercise interventions improve depression and anxiety in chronic kidney disease patients: a systematic review and meta-analysis. International Urology and Nephrology, 53(5), 925–933. https://doi.org/10.1007/s11255-020-02612-w
Hall, J. E., Carmo, J. M., Silva, A. A., Wang, Z., & Hall, M. E. (2019). Obesity, kidney dysfunction and hypertension: mechanistic links. Nature Reviews Nephrology, 15(6), 367–385. https://doi.org/10.1038/s41581-019-0145-4
Hall, J., Juncos, L., Wang, Z., Hall, M., Carmo, J., & Silva, A. (2014). Obesity, hypertension, and chronic kidney disease. International Journal of Nephrology and Renovascular Disease, 7, 75. https://doi.org/10.2147/IJNRD.S39739
Heymsfield, S. B., & Wadden, T. A. (2017). Mechanisms, Pathophysiology, and Management of Obesity. New England Journal of Medicine, 376(3), 254–266. https://doi.org/10.1056/nejmra1514009
Jantaratnotai, N., Mosikanon, K., Lee, Y., & McIntyre, R. S. (2017). The interface of depression and obesity. Obesity Research & Clinical Practice, 11(1), 1–10. https://doi.org/10.1016/j.orcp.2016.07.003
Johansen, K. L., & Carol, L. (2017). Body composition in chronic kidney disease Kirsten. Physiology & Behavior, 176(10), 139–148. https://dx.doi.org/10.1097%2FMNH.0000000000000120
Katon, W. J. (2011). Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues in Clinical Neuroscience, 13(1), 7–23.
KDIGO. (2013). KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International Supplements, 3(1), 2–150. https://doi.org/10.1038/kisup.2012.74
Lee, M. C., Wu, S. F. V., Hsieh, N. C., & Tsai, J. M. (2016). Self-Management Programs on eGFR, Depression, and Quality of Life among Patients with Chronic Kidney Disease: A Meta-Analysis. Asian Nursing Research, 10(4), 255–262. https://doi.org/10.1016/j.anr.2016.04.002
McDougall, K. A., Larkin, J. W., Wingard, R. L., Jiao, Y., Rosen, S., Ma, L., Usvyat, L. A., & Maddux, F. W. (2018). Depressive affect in incident hemodialysis patients. Clinical Kidney Journal, 11(1), 123–129. https://doi.org/10.1093/ckj/sfx054
Milaneschi, Y., Simmons, W. K., van Rossum, E. F. C., & Penninx, B. W. (2019). Depression and obesity: evidence of shared biological mechanisms. Molecular Psychiatry, 24(1), 18–33. https://doi.org/10.1038/s41380-018-0017-5
Ortega, F. B., Lavie, C. J., Bovet, P., Sui, X., & Chiolero, A. (2017). Trial of Tocilizumab in Giant-Cell Arteritis. New England Journal of Medicine, 377(15), 1493–1495. https://doi.org/10.1056/nejmc1711031
Read, J. R., Sharpe, L., Modini, M., & Dear, B. F. (2017). Multimorbidity and depression: A systematic review and meta-analysis. Journal of Affective Disorders, 221, 36–46. https://doi.org/10.1016/j.jad.2017.06.009
Shirazian, S. (2019). Depression in CKD: Understanding the Mechanisms of Disease. Kidney International Reports, 4(2), 189–190. https://doi.org/10.1016/j.ekir.2018.11.013
Silva Junior, G. B., Bentes, A. C. S. N., Daher, E. D. F., & Matos, S. M. A. (2017). Obesity and kidney disease. Jornal Brasileiro de Nefrologia, 39(1), 65–69. https://doi.org/10.5935/0101-2800.20170011
Valle, L. S., Souza, V. F., & Ribeiro, A. M. (2013). Stress and anxiety in chronic renal patients undergoing hemodialysis. Estudos de Psicologia, 30(1), 131–138. https://doi.org/10.1590/s0103-166x2013000100014
Wen, X., Wang, Y., Zhao, Q., Zhang, H., Shi, H., Wang, M., & Lu, P. (2020). Nonpharmacological Interventions for Depressive Symptoms in End-Stage Renal Disease: A Systematic Review. Western Journal of Nursing Research, 42(6), 462–473. https://doi.org/10.1177/0193945919857540
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Marvery Duarte, Heitor Ribeiro, Thalita Ferreira, Victor Baião, Antônio Inda-Filho, Aparecido Ferreira
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International License.
